---
title: "Carecloud Pref Share CCLDO 8.75 Prep 02/15/24 B | 10-Q: FY2025 Q1 Revenue: USD 27.63 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/238983571.md"
datetime: "2025-05-06T20:34:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/238983571.md)
  - [en](https://longbridge.com/en/news/238983571.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/238983571.md)
generator: "portal-rs"
---

# Carecloud Pref Share CCLDO 8.75 Prep 02/15/24 B | 10-Q: FY2025 Q1 Revenue: USD 27.63 M

Revenue: As of FY2025 Q1, the actual value is USD 27.63 M.

EPS: As of FY2025 Q1, the actual value is USD -0.04.

EBIT: As of FY2025 Q1, the actual value is USD 1.989 M.

### Healthcare IT Segment

-   **Net Revenue**: $24,643,000 for the three months ended March 31, 2025, compared to $22,721,000 for the same period in 2024.
-   **Operating Expenses**: Direct operating costs were $12,904,000, selling and marketing expenses were $1,124,000, general and administrative expenses were $2,112,000, research and development expenses were $1,235,000, and depreciation and amortization were $3,255,000 for the three months ended March 31, 2025.
-   **Operating Income**: $3,899,000 for the three months ended March 31, 2025, compared to $756,000 for the same period in 2024.

### Medical Practice Management Segment

-   **Net Revenue**: $2,989,000 for the three months ended March 31, 2025, compared to $3,241,000 for the same period in 2024.
-   **Operating Expenses**: Direct operating costs were $2,560,000, selling and marketing expenses were $7,000, general and administrative expenses were $642,000, and depreciation and amortization were $82,000 for the three months ended March 31, 2025.
-   **Operating Loss**: -$302,000 for the three months ended March 31, 2025, compared to $79,000 operating income for the same period in 2024.

### Cash Flow

-   **Net Cash Provided by Operating Activities**: $5,113,000 for the three months ended March 31, 2025, compared to $4,066,000 for the same period in 2024.
-   **Net Cash Used in Investing Activities**: -$1,510,000 for the three months ended March 31, 2025, compared to -$1,868,000 for the same period in 2024.
-   **Net Cash Used in Financing Activities**: -$1,932,000 for the three months ended March 31, 2025, compared to -$1,374,000 for the same period in 2024.

### Future Outlook and Strategy

-   **Core Business Focus**: The company plans to continue enhancing its liquidity and financial position by managing expenses and growing revenue, with a focus on overall profitability.
-   **Non-Core Business**: The company completed an acquisition of an audiology-focused revenue cycle management company in April 2025, with consideration to be paid over the next 3.5 years based on collected revenue.

### Related Stocks

- [CCLDO.US](https://longbridge.com/en/quote/CCLDO.US.md)

## Related News & Research

- [PepsiCo Hasn't Been This Cheap Relative to Free Cash Flow in 10 Years. Here's Why That's the Signal to Buy.](https://longbridge.com/en/news/298135920.md)
- [Goldman sees $120/bbl oil risk if attacks on Middle East vessels intensify, Bloomberg reports](https://longbridge.com/en/news/298161346.md)
- [Does IMAAVY’s Approval and Ongoing Talc Verdict Meaningfully Shift the Bull Case for Johnson & Johnson (JNJ)?](https://longbridge.com/en/news/298140186.md)
- [Should Williams-Sonoma’s (WSM) Upgraded 2026 Outlook Amid Tariffs Require Action From Investors?](https://longbridge.com/en/news/298137578.md)
- [Tesla Stock And Global Auto Rivals As Buyers Shift From UK Legacy Brands](https://longbridge.com/en/news/298137549.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**